StriveStudy
Clinical trials data collection and digital biomarker development for neuromodulation therapeutics.
Overview
StriveStudy, developed by Rune Labs, is a GCP-compliant, cloud-based clinical trials platform purpose-built for life sciences companies working in neuromodulation and therapeutics development. It provides a comprehensive, wrap-around solution for clinical trial management, supporting data collection, enriched patient recruitment, and longitudinal research across the full product life-cycle.
The platform ingests and leverages longitudinal, multi-modal data to create fit-for-purpose datasets, enabling life sciences partners to address complex research needs with greater speed and confidence. Rune Labs positions itself as a collaborative partner at every stage of development, from early-phase trials through to commercial deployment.
Core Platform Capabilities
- GCP-compliant, cloud-based infrastructure designed for regulated clinical research environments
- Baseline and long-term data collection to support both early and late-stage research
- Ingestion and integration of longitudinal, multi-modal data sources
- Development of novel digital biomarkers to advance neuromodulation research
- Tools and workflows to improve patient compliance throughout the duration of studies
- Creation of fit-for-purpose datasets tailored to specific partner research objectives
Partnership Solutions for Life Sciences
- Clinical Trials Solutions: End-to-end support for the design and execution of clinical trials, including data collection and enriched recruitment capabilities
- Real World Evidence Solutions: Capabilities to capture and analyse real-world data, enabling evidence generation beyond the controlled trial setting
- Commercial Channel Solutions: Support for life sciences partners at the commercial stage, leveraging platform data and infrastructure to drive post-market insights
StriveStudy is offered by Rune Labs, whose team of engineers and scientists works directly alongside life sciences partners across the entire therapeutic development life-cycle. The platform's GCP compliance and cloud-based architecture make it suitable for organisations operating within regulated research and clinical environments.